Document is current
Any future updates will be listed below
-
Authors
König, Kirsten
Pechmann, Astrid
Thiele, Simone
Walter, Maggie C.
Schorling, David
Tassoni, Adrian
Lochmüller, Hanns
Müller-Reible, Clemens
Kirschner, Janbernd https://orcid.org/0000-0003-1618-7386
-
Funding
Funding for this research was provided by:
Roche (0)
PTC Therapeutics (0)
Santhera Pharmaceuticals (0)
Biogen (0)
- License Information
-
More Information
Article History
Received: 13 March 2019
Accepted: 11 June 2019
First Online: 24 June 2019
Ethics approval and consent to participate
: Of the central ethics committee has been obtained (Ethics Committee of the University of Freiburg, Germany (EK 546/15)).
: Not applicable.
: JK received research funding and/or compensation for presentations and consultancy from Avexis, Biogen, Ionis Pharmaceuticals, Novartis, and Roche. HL received research funding and/or compensation for presentations and consultancy from AMO Pharma, Biogen, Desitin, Roche, Santhera, Sarepta, Satellos, Ultragenyx. AP received compensations for presentations and training activities from Biogen. DS participated in workshops sponsored by Biogen. MCW received research funding and/or compensation for presentations and consultancy from Avexis, Biogen, Grünenthal, Novartis, PTC, Roche, Santhera, and Sarepta.
